A new study by investigators at Dana-Farber Cancer Institute and Harvard Medical School is providing one of the most detailed ...
A new research perspective was published in Oncotarget's Volume 15 on January 24, 2024, entitled, "Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic ...
SALT LAKE CITY, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the substantial completion of its strategic ...
Beijing Zhongke Journal Publising Co. Ltd. Through genotyping of regenerated events, the authors first showed that 97% of 104 elite soybean genotypes (101) were simultaneously transformed and the ...
In a report released on August 7, Puneet Souda from Leerink Partners maintained a Buy rating on Myriad Genetics (MYGN – Research Report), with a price target of $35.00. Puneet Souda has given his Buy ...
WASHINGTON (AP) Humankind stands on the verge of a new era of breakthroughs in treating disease thanks to the sequencing of the human genome, scientists told lawmakers Wednesday. The promise of this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback